“…The selected examples depicted in Figure 1 include human bradykinin B1, [1] vitamin B5, [2] an androgen antagonist, [3] a peptidomimetic inhibitor, [4] and a pyruvate dehydrogenase kinase 1 (PDK1) inhibitor. [5] Some recent synthetic approaches to these compounds include decarbonylative alkylation, [6] asymmetric 1,2-carbamoyl rearrangements, [7] arginine-catalyzed Henry type reaction, [8] hydrosilylation reaction, [9] and aminocarbonylation. [10] These approaches usually involve harsh reaction conditions and the use of more complex starting materials.…”